NOW we must change the #melanoma management guidelines across the world. #Neoadjuvant #immunotherapy better than adjuvant in resectable stage 3&4 melanoma SWOG1801 HR 0.58 p0.004 fir event-free survial

Congratulations on a great study!

Congratulations, Heather!

Great to catch up with these guys after the meeting! Thanks ⁦Ravi Uppaluri, MDPhD⁩ and ⁦Jack Bui⁩ for organizing. ⁦R. Bryan Bell, MD, DDS, FACS, FRCS(Ed)⁩ ⁦Society for Immunotherapy of Cancer⁩

Thanks for visiting and presenting a wonderful talk to our group, Dr. Bruno!⁦Tullia Bruno, PhD⁩ Fascinating work on B cells and TLS in head and neck cancer.

Evidence is mounting for changing radiotherapy dogma in the immunotherapy era. nature.com/articles/s4146…

Great catching up with these awesome NK cell scientists! ⁦Fehniger Lab⁩ , Ronnie Freud, ⁦Jennifer Foltz, PhD⁩. #AAI2023 #NKCell #ILC

Looking forward to having you join the Cutaneous Oncology team Stanford Cancer Institute, Pauline!

Great talk yesterday at the AACR–American Head & Neck Society conference in Montreal by Dr. Nate Nathan Reticker-Flynn, our newest faculty member in the Stanford Head & Neck Division. AACR AHNS Stanford Otolaryngology - Head & Neck Surgery StanfordHNSurgery Stanford Cancer Institute Stanford Immunology #AACR-AHNS

Terrific podium presentations at the AHNS Conference by ⁦Stanford Medicine⁩ resident trainees (Joanne Soo & Alice Huang) and students (⁦Sai Maddineni)⁩ in ⁦the Dept of Otolaryngology — HNS. Stanford Otolaryngology - Head & Neck Surgery⁩ ⁦⁦AHNS⁩ ⁦StanfordHNSurgery⁩

🏆 We are honored to announce that we have been ranked #1 in Ear Nose and Throat (ENT) care by U.S. News Health for the second consecutive year! 🎉 #stanfordohns #usnewsworldreport #ent #entdepartment #otolaryngology #stanfordmedicine #stanfordhealthcare

Just out from the #Karamlab cell.com/cell-reports-m…

Important new work from Ravi Uppaluri, MDPhD and Cathy Wu Dana-Farber showing the importance of ZNF683 (HOBIT)-expressing tissue-resident CD8 T cells for response to PD-1 checkpoint blockade. AHNS @NIDCR National Cancer Institute Science Immunology science.org/doi/10.1126/sc…

Clinical Day at #NK2023 is finally here, officially opened by Kalle Malmberg, we are all super excited to learn the latest on clinical developments on NK cells!

Looking forward to working with the #Pacific-Stanford Team on this ambitious ⁦@NIDCR⁩ grant. ⁦University of the Pacific⁩ ⁦Dugoni School (@dugonidental.bsky.social)⁩ ⁦Stanford Medicine⁩ ⁦Stanford University⁩ ⁦John B. Sunwoo, M.D.⁩ linkedin.com/posts/david-k-…

Excited about this collaboration btw Stanford Otolaryngology - Head & Neck Surgery and Dr. David Lam & Team David K. Lam MD, DDS, PhD, FACS at Univ of the Pacific Dental School Dugoni School (@dugonidental.bsky.social) to train the next gen of oral health clinician-scientists w/funding from @NIDCR. Stanford Medicine Stanford Cancer Institute dental.pacific.edu/pacific-newsro…

merck.com/news/mercks-ke… Robert Haddad Glenn J. Hanna, M.D. R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) Robert Ferris, MD, PhD Nabil Saba, MD Schmitt Lab Jonathan Schoenfeld Dr. Gavin P. Dunn Toni Choueiri, MD Kartik Sehgal

For nearly two decades, recombinant erythropoietin has carried a black box warning due to its potential to increase tumor growth. In this excellent study, the authors uncover important roles for EPO in suppressing anti-tumor immunity. Congrats David and team!